跳至主要内容
临床试验/NL-OMON55882
NL-OMON55882已完成4 期

*A prospective randomized multicenter study to demonstrate the superiority of the Barricaid® to discectomy for primary lumbar disc herniation*: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and Interaction with Other Risk Factors - EUBARD*CP*011

Intrinsic Therapeutics, GmbH0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Only subjects enrolled in the original RCT protocol EUBARD-CP-001 will be
  • eligible for long-term follow-up.
  • Original inclusion criteria included: subjects with radiculopathy (with or
  • without back pain), a positive straight leg raise (L4-5, L5-S1) or femoral
  • stretch test (L1-2, L2-3, L3-4), and a posterior or posterolateral herniation
  • at one level between L1 and S1 with radiographic confirmation of neural
  • compression using MRI who are found to have an anular defect (post discectomy)
  • which measures between 4mm and 6mm tall and between 6mm and 10mm wide, with a
  • minimum posterior disc height of 5mm, and failed at least 6 weeks of
  • conservative treatment.

排除标准

  • Only subjects enrolled in the original RCT protocol EUBARD-CP-001 will be
  • eligible for long-term follow-up.
  • Subjects who have died or withdrawn consent during follow-up of RCT
  • EUBARD-CP-001 will not be included in the patient population eligible for this
  • long-term evaluation.

研究者

相似试验